Waku K |
[Endogenous cannabinoid receptor ligands--anandamide and 2-arachidonoylglycerol]. |
2006 |
Yakugaku Zasshi |
pmid:16462096
|
Guagnini F et al. |
Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P. |
2006 |
Gut |
pmid:16423891
|
Avraham Y et al. |
Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice. |
2006 |
Neurobiol. Dis. |
pmid:16102970
|
D'Argenio G et al. |
Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation. |
2006 |
FASEB J. |
pmid:16403786
|
Suplita RL et al. |
Endocannabinoids at the spinal level regulate, but do not mediate, nonopioid stress-induced analgesia. |
2006 |
Neuropharmacology |
pmid:16316669
|
Juan-Picó P et al. |
Cannabinoid receptors regulate Ca(2+) signals and insulin secretion in pancreatic beta-cell. |
2006 |
Cell Calcium |
pmid:16321437
|
Oka S et al. |
Suppression by WIN55212-2, a cannabinoid receptor agonist, of inflammatory reactions in mouse ear: Interference with the actions of an endogenous ligand, 2-arachidonoylglycerol. |
2006 |
Eur. J. Pharmacol. |
pmid:16647054
|
Melis M et al. |
Protective activation of the endocannabinoid system during ischemia in dopamine neurons. |
2006 |
Neurobiol. Dis. |
pmid:16762556
|
Malcher-Lopes R et al. |
Opposing crosstalk between leptin and glucocorticoids rapidly modulates synaptic excitation via endocannabinoid release. |
2006 |
J. Neurosci. |
pmid:16775153
|
Kishimoto S et al. |
Chemotaxis of human peripheral blood eosinophils to 2-arachidonoylglycerol: comparison with other eosinophil chemoattractants. |
2006 |
Int. Arch. Allergy Immunol. |
pmid:16772720
|
Hermann A et al. |
2-Arachidonoylglycerol (2-AG) membrane transport: history and outlook. |
2006 |
AAPS J |
pmid:16808043
|
Yoshida T et al. |
Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. |
2006 |
J. Neurosci. |
pmid:16672646
|
Sugiura T et al. |
Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. |
2006 |
Prog. Lipid Res. |
pmid:16678907
|
Katona I et al. |
Molecular composition of the endocannabinoid system at glutamatergic synapses. |
2006 |
J. Neurosci. |
pmid:16723519
|
Cisneros JA et al. |
Structure-activity relationship of a series of inhibitors of monoacylglycerol hydrolysis--comparison with effects upon fatty acid amide hydrolase. |
2007 |
J. Med. Chem. |
pmid:17764163
|
Saario SM and Laitinen JT |
Monoglyceride lipase as an enzyme hydrolyzing 2-arachidonoylglycerol. |
2007 |
Chem. Biodivers. |
pmid:17712832
|
Vadivel SK et al. |
Conformationally constrained analogues of 2-arachidonoylglycerol. |
2007 |
Bioorg. Med. Chem. Lett. |
pmid:17826996
|
Scutt A and Williamson EM |
Cannabinoids stimulate fibroblastic colony formation by bone marrow cells indirectly via CB2 receptors. |
2007 |
Calcif. Tissue Int. |
pmid:17205329
|
Opitz CA et al. |
Production of the endocannabinoids anandamide and 2-arachidonoylglycerol by endothelial progenitor cells. |
2007 |
FEBS Lett. |
pmid:17904123
|
Mukhopadhyay S and Tulis DA |
Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke. |
2007 |
Cardiovasc Hematol Agents Med Chem |
pmid:17979695
|